With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

"We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," said Dr. Chris Mansi, CEO and co-founder at Viz.ai. “For many with HCM, the path to diagnosis and ...

GE Healthcare has added to its AI capabilities over the past two years, inking deals to buy software from Intelligent ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Poul will take over the company in January after spending 11 years with 3M and working at Medtronic and Boston Scientific.

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...